Nyxoah SA Ordinary Shares NYXH 深 沪
已收盘 09-05 16:00:00 美东时间
5.93
+0.230
+4.04%
华盛通- 最 高5.93
- 今 开5.68
- 成交量 3.21万股
- 最 低 5.65
- 昨 收 5.70
- 总市值 2.22亿
- 52周最高 11.87
- 市盈率 静 --
- 换手率 0.09%
- 52周最低 5.55
- 委 比 44.14%
- 总股本 3744.11万
- 历史最高 37.00
- 量 比 0.49
- 振 幅 4.91%
- 历史最低 4.00
- 每 手 1
- 风险率 3.18%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Nyxoah Announces Transparency Notification on Shareholding Changes
The latest update is out from Nyxoah ( ($NYXH) ). Nyxoah SA has announced a tra...
今天 10:02
Nyxoah Announces Upcoming Investor Events
Nyxoah, a medical technology company developing solutions for Obstructive Sleep Apnea (OSA), announced its participation in several investor events in September 2025, including the Wells Fargo Healthcare Conference, Cantor Global Healthcare Conference, Morgan Stanley Global Healthcare Conference, and Baird's Global Healthcare Conference. The Company will host live webcasts of these events and be available for one-on-one meetings with investors.
09-02 20:30
电话会总结 ｜ Nyxoah(NYXH)2025财年Q2业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• **财务业绩**： Nyxoah (NYXH) 在2025年的营收为140万美元，与2024年的80万美元相比增长了73.8%。2025年的毛利率为63.4%，与2024年持平。2025年的运营亏损为2120万美元，而2024年为1420万美元。公司截至2025年6月30日的现金储备（包括现金、现金等价物和金融资产）为4590万美元，而截至2025年3月31日为6730万美元。</p> <p>• **财务指标变化**： - **营收**：同比增长73.8%，从2024年的80万美元增长至2025年的140万美元。 - **毛利
08-19 12:01
Nyxoah’s Genio System Gains FDA Approval
Nyxoah Sa ( ($NYXH) ) has released its Q2 earnings. Here is a breakdown of the ...
08-19 11:55
Nyxoah Launches Genio System in U.S. Following FDA Approval
Nyxoah ( ($NYXH) ) has provided an update. On August 18, 2025, Nyxoah SA announ...
08-19 05:17
Nyxoah Q2 EPS $(0.62) Beats $(0.63) Estimate, Sales $1.519M Miss $1.730M Estimate
Nyxoah (NASDAQ:NYXH) reported quarterly losses of $(0.62) per share which beat the analyst consensus estimate of $(0.63) by 1.59 percent. This is a 34.78 percent decrease over losses of $(0.46) per share from the same
08-19 04:45
Nyxoah GAAP EPS of -€0.55, revenue of €1.34M
Nyxoah press release (NASDAQ:NYXH): Q2 GAAP EPS of -€0.55. Revenue of €1.34M (+74.0% Y/Y). More on Nyxoah Nyxoah sees Q2 revenue up 73%, plans R&D shift to U.S. and Belgium; shares rise Seeking Alpha’...
08-19 04:17
Nyxoah Reports Second Quarter Financial and Operating Results
Nyxoah reported Q2 2025 financial results, highlighting FDA approval of the Genio system for the U.S. market. Revenue increased 74% YoY to €1.3 million, with €43 million in cash. Operating loss was €20.6 million, driven by commercial prep and R&D. The Genio system, a bilateral hypoglossal neurostimulation therapy, offers unique features like MRI compatibility and is now commercially available in the U.S.
08-18 20:10
Earnings Scheduled For August 18, 2025
Companies Reporting Before The Bell • SUNation Energy (NASDAQ:SUNE) is likely t...
08-18 16:32
Uncovering Potential: Nyxoah's Earnings Preview
Nyxoah (NASDAQ:NYXH) is set to give its latest quarterly earnings report on Mon...
08-15 22:02
